Also known as: Dynastat (brand); Sodium parecoxib
Parecoxib Sodium is the sodium salt form of parecoxib, a selective COX-2 inhibitor prodrug. It is formulated for parenteral administration and used for the short-term management of acute postoperative pain. Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 198470-85-8 |
| Molecular Formula | C19H19NNaO6S |
| Molecular Weight | 399.41 g/mol |
| Grade | IP / BP / USP |
| Category | COX-2 Inhibitor / NSAID / Parenteral Analgesic |
| Appearance | White to off-white, crystalline powder |
| Solubility | Practically insoluble in water, freely soluble in methanol and soluble in ethanol |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PRX/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Parecoxib Sodium — CAS 198470-85-8 (CAS 198470-85-8) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Parecoxib Sodium — CAS 198470-85-8 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance